Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment
- 14 May 2004
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 278 (2) , 407-414
- https://doi.org/10.1016/j.ijpharm.2004.03.018
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Biodistribution of dual radiolabeled lipidic nanocapsules in the rat using scintigraphy and γ countingInternational Journal of Pharmaceutics, 2002
- Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticlesJournal of Pharmaceutical Sciences, 2001
- Capture of Stealth Nanoparticles by the Body’s DefencesCritical Reviews in Therapeutic Drug Carrier Systems, 2001
- The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administrationColloids and Surfaces B: Biointerfaces, 2000
- Peri‐operative use of nonsteroidal anti‐inflammatory drugs in children: analgesic efficacy and bleedingAnaesthesia, 1997
- Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheresJournal of Microencapsulation, 1997
- Occupational Contact Dermatitis to PropacetamolDermatology, 1997
- An investigation on the role of plasma and serum opsonins on the evternalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytesLife Sciences, 1995
- Factors Affecting the Oral Uptake and Translocation of Polystyrene Nanoparticles: Histological and Analytical EvidenceJournal of Drug Targeting, 1995
- Biodegradable Long-Circulating Polymeric NanospheresScience, 1994